Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first‐line treatment of advanced esophageal squamous cell carcinoma

Cancer Communications ◽

10.1002/cac2.12119 ◽

2020 ◽

Vol 40 (12) ◽

pp. 711-720

Author(s):

Bo Zhang ◽

Ling Qi ◽

Xi Wang ◽

Jianping Xu ◽

Yun Liu ◽

...

Keyword(s):

Clinical Trial ◽

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Clinical Trial ◽

Line Treatment ◽

First Line Treatment

Download Full-text

Randomized Phase II Trial of Capecitabine Plus Cisplatin Versus Paclitaxel as First Line Treatment for Metastatic Esophageal Squamous Cell Carcinoma

Annals of Oncology ◽

10.1093/annonc/mdt203.59 ◽

2013 ◽

Vol 24 ◽

pp. iv53

Author(s):

Su Jin Lee ◽

Silvia Park ◽

Wonjin Chang ◽

Jung Yong Hong ◽

Moon Ki Choi ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Line Treatment ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study

10.1186/s12885-015-1716-9 ◽

2015 ◽

Vol 15 (1) ◽

Author(s):

Su Jin Lee ◽

Sungmin Kim ◽

Moonjin Kim ◽

Jeeyun Lee ◽

Yeon Hee Park ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Line Treatment ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

66P Camrelizumab combined with paclitaxel and nedaplatin in the first-line treatment of locally advanced/advanced esophageal squamous cell carcinoma: A phase II, single-arm, exploratory research

Annals of Oncology ◽

10.1016/j.annonc.2021.10.084 ◽

2021 ◽

Vol 32 ◽

pp. S1400

Author(s):

X. Wang ◽

J. Ma ◽

J. Zhang ◽

Y. Yang ◽

D. Zheng ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Locally Advanced ◽

Exploratory Research ◽

Line Treatment ◽

First Line Treatment

Download Full-text

A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC)

Case Medical Research ◽

10.31525/ct1-nct03958890 ◽

2019 ◽

Author(s):

Keyword(s):

Clinical Trial ◽

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Locally Advanced ◽

Line Treatment ◽

First Line Treatment

Download Full-text

1448P Paclitaxel and cisplatin combined with anlotinib as first line regimen for advanced esophageal squamous cell carcinoma (ESCC): A single-arm, multicentre open-label phase II clinical trial

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1954 ◽

2020 ◽

Vol 31 ◽

pp. S910-S911

Author(s):

J-S. Wang ◽

T. Wu ◽

Y-G. Hong ◽

Y-Z. Guo ◽

S-X. Luo ◽

...

Keyword(s):

Clinical Trial ◽

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Clinical Trial ◽

Open Label Phase

Download Full-text

Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma（ESCC）.

Case Medical Research ◽

10.31525/ct1-nct04063683 ◽

2019 ◽

Author(s):

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Line Treatment ◽

First Line Treatment

Download Full-text

972TiP Phase II study of intratumoral MK-1454 plus pembrolizumab compared with pembrolizumab monotherapy as first-line treatment for metastatic or unresectable, recurrent head and neck squamous cell carcinoma

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1087 ◽

2020 ◽

Vol 31 ◽

pp. S683

Author(s):

K.J. Harrington ◽

W.N. William ◽

A. Khilnani ◽

A.P. Algazi

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Line Treatment ◽

Recurrent Head ◽

First Line Treatment

Download Full-text

A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell carcinoma

10.18632/oncotarget.13602 ◽

2016 ◽

Vol 8 (5) ◽

pp. 7540-7547

Author(s):

Hai-ying Wang ◽

Zhi-hua Yao ◽

Hong Tang ◽

Yan Zhao ◽

Shui-ling Jin ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Clinical Study ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Line Treatment ◽

Retrospective Clinical Study ◽

First Line Treatment

Download Full-text

123MO Monalizumab, cetuximab and durvalumab in first-line treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): A phase II trial

Annals of Oncology ◽

10.1016/j.annonc.2021.10.142 ◽

2021 ◽

Vol 32 ◽

pp. S1432

Author(s):

D.A. Colevas ◽

K. Misiukiewicz ◽

A.T. Pearson ◽

J. Fayette ◽

J.R. Bauman ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Line Treatment ◽

Metastatic Squamous Cell Carcinoma ◽

First Line Treatment

Download Full-text

Faculty Opinions recommendation of Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13355993.791652823 ◽

2012 ◽

Author(s):

Marco Merlano

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Line Treatment ◽

Metastatic Squamous Cell Carcinoma ◽

First Line Treatment

Download Full-text